Mahlangu J - Search Results

1

Mahlangu J, Iorio A, Kenet G. Mahlangu J, et al. Haemophilia. 2022 May;28 Suppl 4(Suppl 4):103-110. doi: 10.1111/hae.14524. Haemophilia. 2022. PMID: 35521723 Free PMC article.

2

Haemophilia care in South Africa: 2004-2007 look back.

Mahlangu JN; Medical and Scientific Council of the South African Haemophilia Foundation. Mahlangu JN, et al. Haemophilia. 2009 Jan;15(1):135-41. doi: 10.1111/j.1365-2516.2008.01807.x. Epub 2008 Aug 12. Haemophilia. 2009. PMID: 18700842

3

Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.

Lochan A, Macaulay S, Chen WC, Mahlangu JN, Krause A. Lochan A, et al. Among authors: mahlangu jn. Haemophilia. 2014 Sep;20(5):687-92. doi: 10.1111/hae.12436. Epub 2014 Jun 21. Haemophilia. 2014. PMID: 24953131

4

Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey.

Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, Holme PA, James P, Kruse-Jarres R, Mahlangu J, Mingot-Castellano ME, Soni A; Global Emerging Hemophilia Panel (GEHEP). Fogarty PF, et al. Among authors: mahlangu j. Haemophilia. 2015 Sep;21(5):589-97. doi: 10.1111/hae.12652. Epub 2015 Feb 17. Haemophilia. 2015. PMID: 25689278

5

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A.

Nolan B, Mahlangu J, Perry D, Young G, Liesner R, Konkle B, Rangarajan S, Brown S, Hanabusa H, Pasi KJ, Pabinger I, Jackson S, Cristiano LM, Li X, Pierce GF, Allen G. Nolan B, et al. Among authors: mahlangu j. Haemophilia. 2016 Jan;22(1):72-80. doi: 10.1111/hae.12766. Epub 2015 Jul 27. Haemophilia. 2016. PMID: 26218032 Clinical Trial.

6

Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery.

Négrier C, Abdul Karim F, Lepatan LM, Lienhart A, López-Fernández MF, Mahlangu J, Pabinger I, Li Y, Wolko D, Voigt C, Jacobs I, Santagostino E. Négrier C, et al. Among authors: mahlangu j. Haemophilia. 2016 Jul;22(4):e259-66. doi: 10.1111/hae.12972. Epub 2016 Jun 22. Haemophilia. 2016. PMID: 27333467 Clinical Trial.

7

Changes in health-related quality of life with treatment of longer-acting clotting factors: results in the A-LONG and B-LONG clinical studies.

Wyrwich KW, Krishnan S, Auguste P, Poon JL, von Maltzahn R, Yu R, Pierce GF, Mei B, Mahlangu J, von Mackensen S. Wyrwich KW, et al. Among authors: mahlangu j. Haemophilia. 2016 Nov;22(6):866-872. doi: 10.1111/hae.12987. Epub 2016 Jul 7. Haemophilia. 2016. PMID: 27385432

8

Extended half-life clotting factor concentrates: results from published clinical trials.

Young G, Mahlangu JN. Young G, et al. Among authors: mahlangu jn. Haemophilia. 2016 Jul;22 Suppl 5:25-30. doi: 10.1111/hae.13028. Haemophilia. 2016. PMID: 27405672

9

Low-factor consumption for major surgery in haemophilia B with long-acting recombinant glycoPEGylated factor IX.

Escobar MA, Tehranchi R, Karim FA, Caliskan U, Chowdary P, Colberg T, Giangrande P, Giermasz A, Mancuso ME, Serban M, Tsay W, Mahlangu JN. Escobar MA, et al. Among authors: mahlangu jn. Haemophilia. 2017 Jan;23(1):67-76. doi: 10.1111/hae.13041. Epub 2016 Aug 1. Haemophilia. 2017. PMID: 27480487

10

TRUST trial: BAY 86-6150 use in haemophilia with inhibitors and assessment for immunogenicity.

Mahlangu J, Paz P, Hardtke M, Aswad F, Schroeder J. Mahlangu J, et al. Haemophilia. 2016 Nov;22(6):873-879. doi: 10.1111/hae.12994. Epub 2016 Aug 8. Haemophilia. 2016. PMID: 27501279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page